A Cassava Sciences collaborator was indicted by a federal grand jury on charges of defrauding the NIH in grant applications supporting the company’s investigational Alzheimer’s drug simufilam, which is now in phase III studies. (Reuters)
A new type of surgical intervention and a prosthetic interface driven by the nervous system helped leg amputees walk naturally. (Nature Medicine)
About a quarter of clinical events reported as relapses in patients with multiple sclerosis were not associated with MRI activity. (JAMA Neurology)
A phase I study of UB-312, an active immunotherapeutic targeting pathological alpha-synuclein, showed promise in Parkinson’s disease. (Nature Medicine)
MRI predicted Parkinson’s progression, a prospective study showed. (Radiology)
Black participants in the ENROLL-HD observational study were diagnosed with Huntington’s disease 1 year later than white participants. (Neurology Clinical Practice)
The New York Times took a closer look at the effects of repeated blast exposure on the brain and Navy SEALS who died by suicide.
The National Academies of Sciences, Engineering, and Medicine recommended steps Congress, federal agencies, and others could take to make amyotrophic lateral sclerosis (ALS) a livable disease in the next 10 years.
High levels of physical activity and fitness were linked with a lower risk of ALS more than 30 years later in men, but not in women. (Neurology)
Atogepant (Qulipta) was effective in chronic migraine, with and without acute medication overuse. (Neurology)
Source link : https://www.medpagetoday.com/neurology/generalneurology/110929
Author :
Publish date : 2024-07-02 18:57:59
Copyright for syndicated content belongs to the linked Source.
